Evaxion Biotech APS
Records under this name other than patents Evaxion Biotech APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,085,631 | Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus Formerly held In force · High confidence | In force | High confidence | |
| US 9,534,022 | Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus Formerly held In force · High confidence | In force | High confidence | |
| US 10,034,928 | Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus Formerly held In force · High confidence | In force | High confidence | |
| US 10,675,340 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus Formerly held In force · High confidence | In force | High confidence | |
| US 11,052,145 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus Formerly held In force · High confidence | In force | High confidence | |
| US 11,807,669 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus Formerly held In force · High confidence | In force | High confidence | |
| US 11,857,615 | Peptides derived from Acinetobacter Baumannii and their use in vaccination Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,434,162 | Proteins and nucleic acids useful in vaccines targeting Klebsiella Pneumoniae Formerly held In force · High confidence | In force | High confidence | |
| US 10,849,968 | Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae Formerly held In force · High confidence | In force | High confidence | |
| US 12,226,469 | Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae Formerly held In force · High confidence | In force | High confidence |